NewAmsterdam Pharma Co N.V. Quarterly Earnings Per Share, Basic in USD/shares from Q1 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
NewAmsterdam Pharma Co N.V. quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2023 to Q3 2024.
  • NewAmsterdam Pharma Co N.V. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.18 USD/shares, a 68.4% increase year-over-year.
  • NewAmsterdam Pharma Co N.V. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -2.25 USD/shares.
  • NewAmsterdam Pharma Co N.V. annual Earnings Per Share, Basic for 2023 was -2.15 USD/shares, a 80.7% decline from 2022.
  • NewAmsterdam Pharma Co N.V. annual Earnings Per Share, Basic for 2022 was -1.19 USD/shares, a 68.8% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$2 $0 +$0.39 +68.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 -$3 $0 +$0.06 +12.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$3 -$1 -$1 -108% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$2 -$1 Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$1 Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $0 Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$1 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.